Cargando…
Kaempferol Downregulates Insulin-like Growth Factor-I Receptor and ErbB3 Signaling in HT-29 Human Colon Cancer Cells
BACKGROUND: Novel dietary agents for colon cancer prevention and therapy are desired. Kaempferol, a flavonol, has been reported to possess anticancer activity. However, little is known about the molecular mechanisms of the anticancer effects of kaempferol. The aim of this study was to determine the...
Autores principales: | Lee, Hyun Sook, Cho, Han Jin, Kwon, Gyoo Taik, Park, Jung Han Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Cancer Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189510/ https://www.ncbi.nlm.nih.gov/pubmed/25337585 http://dx.doi.org/10.15430/JCP.2014.19.3.161 |
Ejemplares similares
-
Mechanisms Underlying Apoptosis-Inducing Effects of Kaempferol in HT-29 Human Colon Cancer Cells
por: Lee, Hyun Sook, et al.
Publicado: (2014) -
Kaempferol Induces Cell Cycle Arrest in HT-29 Human Colon Cancer Cells
por: Cho, Han Jin, et al.
Publicado: (2013) -
Induction of apoptosis and the regulation of ErbB signaling by laminarin in HT-29 human colon cancer cells
por: PARK, HEE-KYOUNG, et al.
Publicado: (2013) -
Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells
por: Lim, Do Young, et al.
Publicado: (2012) -
Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
por: Oh, Yoon Sin, et al.
Publicado: (2011)